Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

PREMIER Biosoft and JEOL Enter Agreement

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
The co-marketing agreement aims to advance research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology.

PREMIER Biosoft and JEOL announce that they have signed a co-marketing agreement for MALDIVision, a MALDI Imaging Mass Spectrometry (MALDI IMS) data analysis tool. The collaboration aims to provide a comprehensive tool for advancing research involving marker studies, drug metabolite profiling, lipid and proteomics analysis using MALDI-IMS technology. Under this agreement, JEOL will promote MALDIVision along with its JMS-S3000 SpiralTOF™ Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometer.

MALDIVision visualizes and analyzes spatial distribution of analytes in a sampled tissue section. MALDIVision is the only tool on the market to seamlessly load and analyze imaging data files up to 20 GB. The program generates high quality reconstituted MALDI images in 2D and 3D based on the m/z value of target compounds. Users can overlay up to 10 MALDI images for visualization of spatial distribution of different compounds present in a sample.

According to Yoshihisa Ueda, the general manager of the Mass Spectrometry Business Unit JEOL Ltd., “Our JMS-S3000 SpiralTOF™ has the highest mass resolving power among any MALDI-TOFMS on the market. This imposes a unique challenge to the imaging data analysis software; the amount of information and, thus, the size of the imaging data from SpiralTOF is also the largest. After rigorous evaluation, we found that MALDIVision can process such data flawlessly. We are quite excited that, by combining SpiralTOF and MALDIVision, now we can offer a powerful and unique solution for the cutting edge research in life science and material science.”

“Mass Spectrometry is a rapidly growing platform for biomarker discovery. This collaboration will provide the research community, especially in the Asia-Pacific region, with a powerful tool to support mass spectrometry based imaging applications,” said Arun Apte, CEO at PREMIER Biosoft.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos